✏ This is your friendly reminder that abstract submissions for Advancing Gene + Cell Therapies for Cancer are due TONIGHT (July 19) at 11:59 p.m. ET. We can't wait to see your work and are accepting all cancer-related abstracts, including those that focus on hematologic and solid tumors. 📌 Notifications are sent to authors on August 19 and abstracts are released to the public on September 30 at 4:30 p.m. ET. 💡 Learn more and submit here: https://lnkd.in/g2JHc4rg #cancerresearch #CGT #ASGCTAdvancing24 #celltherapy #genetherapy #cancerabstracts #ASGCT
American Society of Gene & Cell Therapy
Non-profit Organizations
Waukesha, WI 28,688 followers
ASGCT is the primary membership organization for professionals working in gene and cell therapy.
About us
The American Society of Gene & Cell Therapy is the primary professional membership organization for gene and cell therapy. The Society's members are scientists, physicians, patient advocates, and other professionals. Our members work in a wide range of settings including universities, hospitals, government agencies, foundations, and biotechnology and pharmaceutical companies. The mission of ASGCT is to advance knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease. ASGCT's strategic vision is to be a catalyst for bringing together scientists, physicians, patient advocates, and other stakeholders to transform the practice of medicine by incorporating the use of genetic and cellular therapies to control and cure human disease.
- Website
-
http://www.asgct.org
External link for American Society of Gene & Cell Therapy
- Industry
- Non-profit Organizations
- Company size
- 11-50 employees
- Headquarters
- Waukesha, WI
- Type
- Nonprofit
- Founded
- 1996
Locations
-
Primary
20800 Swenson Dr.
Suite 300
Waukesha, WI 53186, US
Employees at American Society of Gene & Cell Therapy
-
Ravishankar Vadali
-
Serene Forte, PhD, MPH
Rare Diseases | Genetic Medicines | Medical Affairs | Strategy and Leadership | Business Development | Commercialization
-
Aravind Asokan
Professor, Duke University; Biotech Founder
-
Katharine (Katy) Spink
COO & Managing Partner at Dark Horse Consulting Inc.
Updates
-
🌏 Global regulators from Spain, Japan, and the US are coming together to discuss regulatory convergence efforts for advanced therapies. Join #ASGCT on Sept. 23 in DC or virtually for the Global Regulatory Convergence session at the 2024 Policy Summit to hear from Dr. Sol Ruiz (AEMPS, Spain), Dr. Yasuhiro Kishioka (PMDA, Japan), and Dr. Nicole Verdun (FDA CBER, US). Speakers will offer valuable perspectives on the approval process and current regulations. Registration link in comments below. 👇 Don't miss your chance to engage with these decision-makers! #CGTRegulation #GlobalConvergence #AdvancedTherapies #ASGCTAdvocacy
-
From the UW Institute for Stem Cell and Regenerative Medicine: A new #genetherapy for #Duchenne #musculardystrophy shows promise of stopping the decline of affected muscles as well as, in the future, possibly repairing the muscles. Learn more about the findings, which were published in Nature this week by members of ASGCT Immediate Past President Jeffrey Chamberlain's lab! https://lnkd.in/ggRZMYMa
New Gene Therapy for Muscular Dystrophy Offers Hope - Institute for Stem Cell & Regenerative Medicine
https://iscrm.uw.edu
-
The July issue of The Advocate is out NOW! Some highlights: --FDA releases new draft guidance to improve clinical trial enrollment --U.S. Supreme Court overturns Chevron Doctrine --Registration is OPEN for three ASGCT fall events! Join us for the first event, the 2024 Policy Summit, in Washington, D.C. or from anywhere in the world! On Sept. 23-24, Policy Summit presenters will tackle some of the most pressing policy issues in the field, like global regulatory convergence, Medicaid coverage of CGT in the states, and much more! Make sure you're subscribed to get the latest updates from our Policy + Advocacy team! https://lnkd.in/ga8bjqWJ #ASGCTadvocacy
-
📕 Submit your #cancerresearch by TOMORROW (July 19) at 11:59 p.m. ET for the opportunity to present at Advancing Gene + Cell Therapies for Cancer in #Philadelphia, Oct. 16-17! 📕 Link in first comment below! 👇 #Abstracts will highlight all cancer-related research, including #hematologic and solid tumors. Sessions will cover hot-button topics including CAR-T persistence, targeting solid tumors, direct in vivo gene modification, and CAR-induced malignancies. This unique hybrid conference is designed to combine education and overviews by invited faculty with the exciting research conducted by you, the attendees. #callforabstracts #cancerabstracts #CGT #ASGCT
-
💡 As an #ASGCT member, you receive free access to Professional Development Cafés, which facilitate networking, conversation, and understanding of various CGT topics. Join us on August 16 from 1-2 p.m. CT for the Professional Development Café "First-In-Human Gene Therapy with Platelet-Derived Factor VIII for Severe Hemophilia A" with speaker David Wilcox, PhD and moderator Juliana AlvarezArgote, MD. We can't wait for a lively discussion - see you there! https://lnkd.in/e-bPBhsN
This content isn’t available here
Access this content and more in the LinkedIn app
-
Have you listened to the latest episode of The Issue? Host Emily Walsh Martin, PhD talks to David Altshuler, MD, PhD, about how he and his Vertex Pharmaceuticals team think about drug development innovation, how that impacts how they select programs and approaches for the diseases they focus on, what he'd love to see happen with #CGT platform technologies, + more. https://lnkd.in/gJgTR79M #ASGCTPodcastNetwork #genetherapy #CRISPR
CRISPR and Beyond with Vertex CSO David Altshuler, MD, PhD—ASGCT's The Issue
https://www.youtube.com/
-
ASGCT is hiring! Learn more about our open positions and submit an application today. https://lnkd.in/d4CqBBNC
We have two manager roles open with ASGCT! Our Development and Membership teams are looking for outgoing and motivated individuals to support our fundraising and member engagement goals. https://lnkd.in/g-MeZkxe
ASGCT Careers
asgct.org
-
This Thursday, July 18: Catch European Society of Gene and Cell Therapy's Around the World webinar series! From 7-8 a.m. (CT), learn more about #genetherapy in a large animal model of #Stargardt disease as well as liver-directed AAV-mediated mouse models of inherited diseases. Check it out! https://lnkd.in/dBME247
-
TODAY is the first day of the 2024 Biotech Discovery Labs Program! We're looking forward to hearing what our participating Milwaukee Public Schools teachers think about the training this week. Learn more + watch the journey of this program from creation to implementation in the classroom! bit.ly/3WowIPd #scied #meded #genetherapy #biotech